{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:08:34Z","timestamp":1783573714982,"version":"3.55.0"},"reference-count":51,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T00:00:00Z","timestamp":1530662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Psychiatr Scand"],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Depression is a frequent but potentially treatable clinical dimension in patients with schizophrenia spectrum disorders (<jats:styled-content style=\"fixed-case\">PWS<\/jats:styled-content>). However, there is a lack of consensual recommendations regarding the optimal strategy to manage depression in <jats:styled-content style=\"fixed-case\">PWS<\/jats:styled-content>. In this study, we aimed to compare the various proposed strategies to define a core set of valid care recommendations for depression management in <jats:styled-content style=\"fixed-case\">PWS<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>After a systematic search of the literature, the methodological quality of 10 international guidelines from four continents was compared using a validated guideline appraisal instrument (<jats:styled-content style=\"fixed-case\">AGREE II<\/jats:styled-content>). Key recommendations for the management of depression in <jats:styled-content style=\"fixed-case\">PWS<\/jats:styled-content> were subsequently reviewed and discussed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The methodological quality of the guidelines was heterogeneous. Although all guidelines proposed pharmacotherapy, psychosocial interventions were a minor concern. Waiting for antipsychotic effects mostly was recommended during the acute phase of schizophrenia. During the postpsychotic phase of the illness, a switch to a second\u2010generation antipsychotic and\/or the adjunction of an antidepressant were the primary recommendations. Cognitive behavioural therapy and other medications were considered with strong variations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Further studies are needed to strengthen the level of evidence for antidepressive approaches in <jats:styled-content style=\"fixed-case\">PWS<\/jats:styled-content>. The inclusion of <jats:styled-content style=\"fixed-case\">PWS<\/jats:styled-content> as stakeholders is also considered to be a major issue for future guideline development.<\/jats:p><\/jats:sec>","DOI":"10.1111\/acps.12939","type":"journal-article","created":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T02:40:04Z","timestamp":1530758404000},"page":"289-299","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Management of depression in patients with schizophrenia spectrum disorders: a critical review of international guidelines"],"prefix":"10.1111","volume":"138","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5121-8769","authenticated-orcid":false,"given":"C.","family":"Dond\u00e9","sequence":"first","affiliation":[{"name":"INSERM, U1028, CNRS, UMR5292 Lyon Neuroscience Research Center Psychiatric Disorders: From Resistance to Response Team Lyon France"},{"name":"University Lyon 1 Villeurbanne France"},{"name":"Centre Hospitalier Le Vinatier Bron France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Vignaud","sequence":"additional","affiliation":[{"name":"INSERM, U1028, CNRS, UMR5292 Lyon Neuroscience Research Center Psychiatric Disorders: From Resistance to Response Team Lyon France"},{"name":"University Lyon 1 Villeurbanne France"},{"name":"Centre Hospitalier Le Vinatier Bron France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Poulet","sequence":"additional","affiliation":[{"name":"INSERM, U1028, CNRS, UMR5292 Lyon Neuroscience Research Center Psychiatric Disorders: From Resistance to Response Team Lyon France"},{"name":"University Lyon 1 Villeurbanne France"},{"name":"Centre Hospitalier Le Vinatier Bron France"},{"name":"Department of Psychiatry Emergencies CHU Lyon H\u00f4pital Edouard Herriot Lyon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Brunelin","sequence":"additional","affiliation":[{"name":"INSERM, U1028, CNRS, UMR5292 Lyon Neuroscience Research Center Psychiatric Disorders: From Resistance to Response Team Lyon France"},{"name":"University Lyon 1 Villeurbanne France"},{"name":"Centre Hospitalier Le Vinatier Bron France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Haesebaert","sequence":"additional","affiliation":[{"name":"INSERM, U1028, CNRS, UMR5292 Lyon Neuroscience Research Center Psychiatric Disorders: From Resistance to Response Team Lyon France"},{"name":"University Lyon 1 Villeurbanne France"},{"name":"Centre Hospitalier Le Vinatier Bron France"},{"name":"CERVO Brain Research Center Qu\u00e9bec QC Canada"},{"name":"D\u00e9partement de Psychiatrie et Neurosciences Facult\u00e9 de M\u00e9decine Universit\u00e9 Laval Qu\u00e9bec QC Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,7,4]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbw097"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.9.1379"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2006.09.027"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.150.11.1643"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1192\/apt.bp.108.005629"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.10.921"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.177.6.522"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.177.6.522"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.3109\/15622975.2012.696143"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2009.02.002"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1177\/1359786810385490"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/13811118.2012.667328"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/1744-859X-12-32"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0193-953X(18)30644-0"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.07.001"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1177\/0004867416641195"},{"issue":"13","key":"e_1_2_7_19_1","first-page":"7S","article-title":"Clinical practice guidelines. Treatment of schizophrenia","volume":"50","author":"Canadian Psychiatric Association","year":"2005","journal-title":"Can J Psychiatry"},{"key":"e_1_2_7_20_1","first-page":"64","volume-title":"Management of schizophrenia","author":"Scottish Intercollegiate Guidelines Network (SIGN)","year":"2013"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.3109\/15622975.2015.1009163"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.3109\/13651509909068395"},{"key":"e_1_2_7_23_1","first-page":"1","article-title":"Practice guideline for the treatment of patients with schizophrenia, second edition","volume":"2","author":"Lehman AF","year":"2004","journal-title":"Am J Psychiatry"},{"key":"e_1_2_7_24_1","first-page":"2","article-title":"Expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders","volume":"64","author":"Expert Consensus Panel\u00a0for Schizophrenia","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v68n1115"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbp116"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2013.02.008"},{"key":"e_1_2_7_28_1","volume-title":"Psychosis and schizophrenia in adults: prevention and management","author":"National Institute for Health and Clinical Excellence (NICE)","year":"2014"},{"key":"e_1_2_7_29_1","volume-title":"Psychosis and schizophrenia in young people: recognition and management","author":"National Institute for Health and Clinical Excellence (NICE)","year":"2013"},{"key":"e_1_2_7_30_1","volume-title":"Depression in adults: prevention and management","author":"National Institute for Health and Clinical Excellence (NICE)","year":"2016"},{"key":"e_1_2_7_31_1","volume-title":"Depression in children and young people: identification and management","author":"National Institute for Health and Clinical Excellence (NICE)","year":"2015"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881110391123"},{"key":"e_1_2_7_33_1","volume-title":"Manual for beck depression inventory II (BDIII)","author":"Beck AT","year":"1996"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/0920-9964(92)90003-N"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.134.4.382"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.187.3.248"},{"key":"e_1_2_7_37_1","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/jama.1995.03530070068032","article-title":"Users\u2019 guides to the medical literature VIII. How to use clinical practice guidelines. A. Are the recommendations valid? The evidence based medicine work group","volume":"274","author":"Hayward RS","year":"1995","journal-title":"JAMA"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-005-0585-7"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60995-8"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-014-0341-5"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S127623"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbm065"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-7625.2011.00704.x"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0000000000000057"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/NMD.0000000000000296"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31140-0"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1177\/0706743716659418"},{"key":"e_1_2_7_48_1","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1037\/0022-006X.76.3.468","article-title":"Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the prevention of relapse and recurrence in major depression","volume":"76","author":"Dobson KS","year":"2008","journal-title":"J Cons Clin Psychol"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.encep.2017.02.006"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1177\/0004867413502090"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S67477"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2015.07.012"}],"container-title":["Acta Psychiatrica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Facps.12939","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/acps.12939","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T08:25:57Z","timestamp":1694939157000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/acps.12939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,4]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["10.1111\/acps.12939"],"URL":"https:\/\/doi.org\/10.1111\/acps.12939","archive":["Portico"],"relation":{},"ISSN":["0001-690X","1600-0447"],"issn-type":[{"value":"0001-690X","type":"print"},{"value":"1600-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,4]]},"assertion":[{"value":"2018-06-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}